Exenatide significantly improved the high glucose (HG)-induced renal tubular injury in mice and reduced the HG-induced renal tubular epithelial cell death in vitro, suggesting that GLP-1R agonists might have a protective effect on DKD [234]. This evidence concerns the gene GLP1R and diabetic kidney disease.